[1]
Malihe Naderi, Atefeh Saeedi, Abdolvahab Moradi, Mishar Kleshadi, Mohammad Reza Zolfaghari, Ali Gorji, Amir Ghaemi, 2013: Interleukin-12 as a Genetic Adjuvant Enhances Hepatitis C Virus NS3 DNA Vaccine Immunogenicity, Virologica Sinica, 28, 167-173. doi: 10.1007/s12250-013-3291-z
[2]
Zhangsheng Yang, Jun Du, Gang Chen, Jie Zhao, Xuanming Yang, Lishan Su, Genhong Cheng, Hong Tang, 2014: Coronavirus MHV-A59 infects the lung and causes severe pneumonia in C57BL/6 mice, Virologica Sinica, 29, 393-402. doi: 10.1007/s12250-014-3530-y
[3]
Farahnaz Motamedi Sedeh, Hoorieh Soleimanjahi, AmirReza Jalilian, Homayoon Mahravani, 2012: Comparison of Immune Responses against FMD by a DNA Vaccine Encoding the FMDV/O/IRN/2007 VP1 Gene and the Conventional Inactivated Vaccine in an Animal Model, Virologica Sinica, 27, 286-291. doi: 10.1007/s12250-012-3258-5
[4]
Susan L. Uprichard, 2010: Hepatitis C Virus Experimental Model Systems and Antiviral drug Research^*, Virologica Sinica, 25, 227-245. doi: 10.1007/s12250-010-3134-0
[5]
Joachim Lupberger, Mirjam B. Zeisel, Anita Haberstroh, Eva K. Schnober, Sophie Krieger, Eric Soulier, Christine Thumann, Cathy Royer, Samira Fafi-Kremer, Catherine Schuster, Françoise Stoll-Keller, Hubert E. Blum, Thomas F. Baumert, 2008: Virus-host Interactions during Hepatitis C Virus Entry -Implications for Pathogenesis and Novel Treatment Approaches, Virologica Sinica, 23, 124-131. doi: 10.1007/s12250-008-2943-x
[6]
Qingjiao Liao, Jiansheng Tian, Yang Wu, Xulin Chen, 2013: The Identification of Three Sizes of Core Proteins during the Establishment of Persistent Hepatitis C Virus Infection in vitro, Virologica Sinica, 28, 129-135. doi: 10.1007/s12250-013-3296-7
[7]
阮华, 部金荣, 叶林柏, 徐进平, 王晓玲, 赵月娥, 吴正辉, 2001: Expression of Hepatitis C Virus NS5A Gene In E ．coli and Its Application in HCV Antibody Detection, Virologica Sinica, 16, 190-192.
[8]
Si WANG, Qing NIE, Lan-yan ZHENG, Jun HU, En-jie LUO, 2010: In Vivo Kinetics and Biodistribution of a Hantaan Virus DNA Vaccine after Intramuscular Injection in Mice, Virologica Sinica, 25, 177-182. doi: 10.1007/s12250-010-3103-7
[9]
许信刚, 胡建和, 张彦明, 邓宏魁, 2005: Construction of Hepatitis C Virus E1E2 Envelope Protein Gene DNA Vaccine and Animal Immune Experiment, Virologica Sinica, 20, 549-551.
[10]
郑敏, 金宁一, 张洪勇, 李昌, 田明尧, 马鸣潇, 贾雷立, 2005: Prophylaxtic Efficacy of Recombinant Fowl-pox Virus and DNA Vaccine Against Foot-and-Mouth Disease Virus in Guinea Pigs, Virologica Sinica, 20, 379-382.
[11]
Ziyang Sheng, Hui Chen, Kaihao Feng, Na Gao, Ran Wang, Peigang Wang, Dongying Fan, Jing An, 2019: Electroporation-Mediated Immunization of a Candidate DNA Vaccine Expressing Dengue Virus Serotype 4 prM-E Antigen Confers Long-Term Protection in Mice, Virologica Sinica, 34, 88-96. doi: 10.1007/s12250-019-00090-8
[12]
Huadong Wang, Yanfeng Yao, Chaoyang Huang, Quanjiao Chen, Jianjun Chen, Ze Chen, 2013: Immunization with Cytomegalovirus Envelope Glycoprotein M and Glycoprotein N DNA Vaccines can Provide Mice with Complete Protection against a Lethal Murine Cytomegalovirus Challenge, Virologica Sinica, 28, 174-182. doi: 10.1007/s12250-013-3330-9
[13]
Huang Cao, Wandi Zhu, Qingxia Han, Rongjuan Pei, Xinwen Chen, 2014: Construction of a chimeric hepatitis C virus replicon based on a strain isolated from a chronic hepatitis C patient, Virologica Sinica, 29, 61-70. doi: 10.1007/s12250-014-3408-z
[14]
李子健, 金宁一, 张立树, 江文正, 张洪勇, 2004: Humoral and Cellular Immunogenecity of DNA Vaccine of HIV-2 Chimeric Gene gag-gp105 in BALB/c, Virologica Sinica, 19, 559-562.
[15]
Hong-bo FAN, Jun-wei LI, Zhi-lin LI, Wei ZHENG, Po Tien, De-yin GUO, 2007: Cloning of M and NP Gene of H5N1 Avian Influenza Virus and Immune Efficacy of their DNA Vaccines, Virologica Sinica, 22, 46-52.
[16]
单梅梅, 刘克洲, 陈智, 2000: DNA Vaccination of the Induction of Imm une Responses by Hepatitis C Strutural Antigens, Virologica Sinica, 15, 14-21.
[17]
Chinwe O. Ewenighi-Amankwah, Charles Chinedum Onyenekwe, Ogochukwu Udemba, Patience Muogbo, Lijun Rong, 2020: A Mother-to-Child Transmission Study in Nigeria: The Impact of Maternal HIV Infection and HAART on Plasma Immunoglobulins, Cytokine Profiles and Infant Outcome, Virologica Sinica, 35, 468-477. doi: 10.1007/s12250-020-00202-9
[18]
高阳, 江丽芳料, 方丹云, 曾祥凤, 2003: Eukaryotic Expressing and the DNA Immunization of E Protein Gene ofDengue virus 2, Virologica Sinica, 18, 201-205.
[19]
Jia Guo, Ran Yan, Guo-dong Xu, Cong-yi Zheng, 2012: HCV NS5A and NS5B Enhance Expression of Human Ceramide Glucosyltransferase Gene, Virologica Sinica, 27, 38-47. doi: 10.1007/s12250-012-3226-0
[20]
Ran Jia, Xiangshi Wang, Pengcheng Liu, Xiaozhen Liang, Yanling Ge, He Tian, Hailing Chang, Hao Zhou, Mei Zeng, Jin Xu, 2020: Mild Cytokine Elevation, Moderate CD4⁺ T Cell Response and Abundant Antibody Production in Children with COVID-19, Virologica Sinica, 35, 734-743. doi: 10.1007/s12250-020-00265-8